Article
The impact of endotrophin on the progression of chronic liver disease.
Experimental & molecular medicine - 1 Oct 2020
Kim Min, Lee Changhu, Seo Dae Yun, Lee Hyojung, Horton Jay D, Park Jiyoung, Scherer Philipp E
Abstract excerpt
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease and can lead to multiple complications, including non-alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma. The fibrotic liver is characterized by the pathological accumulation of extracellular matrix (ECM) proteins. Type VI collagen alpha3 (Col6a3) is a biomarker of hepatic fibrosis, and its cleaved form, endotrophin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
